Diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI protocol for hepatocellular carcinoma screening
To evaluate the diagnostic per-lesion performance of a simulated gadoxetate disodium-enhanced abbreviated MRI (AMRI) in cirrhotic and chronic hepatitis B (CHB) patients for hepatocellular carcinoma (HCC) screening.
Source: Clinical Radiology - Category: Radiology Authors: B.G. Tillman, J.D. Gorman, J.M. Hru, M.H. Lee, M.C. King, C.B. Sirlin, R.M. Marks Source Type: research
More News: Cancer & Oncology | Carcinoma | Hepatitis | Hepatitis B | Hepatocellular Carcinoma | Liver Cancer | Radiology